March 23, 2015
The U.S. Food and Drug Administration (FDA) will hold a public meeting entitled, “FDA Food Safety Modernization Act: Focus on Implementation Strategy for Prevention-Oriented Food Safety Standards.” The meeting will be held April 23, 2015, 8:30 a.m. to 5:30 p.m. and April 24, 2015, 8:30 a.m. to 12:30 p.m. at the Washington Marriott Hotel at Metro Center, 775 12th Street, NW, Washington, DC 20005.
The public meeting will provide an opportunity to learn about and discuss FDA’s current planning efforts for the next phase of the FDA Food Safety Modernization Act (FSMA) implementation, which involves putting in place the prevention and risk-based safety standards at the core of FSMA. FDA will share current thinking on operational strategies for implementing the new standards that will affect food and feed facilities, farmers, importers and others who supply the nations’ food. While there is no formal public comment session planned, it is anticipated that stakeholders will have ample opportunity to provide comments and opinions through their participation in their choice of breakout sessions on the topics discussed at the meeting and to engage in an open comment and question/answer session.
Attendees are encouraged to register on-line to attend the meeting in person and via live Webcast or contact: Courtney Treece, Planning Professionals Ltd., 1210 W. McDermott St., Suite 11, Allen, TX 75013, telephone: 704-258-4983, FAX: 469-854-6992, e-mail: email@example.com. Early registration is strongly recommended because seating is limited.
For general questions about the meeting and to request special accommodations due to a Disability, contact: Juanita Yates, FDA, Center for Food Safety and Applied Nutrition, telephone: 240-402-1731, e-mail: Juanita.Yates@fda.hhs.gov.
Registration and Additional Information:
Please note the following important dates:
- April 8, 2015: Closing date to request special accommodation due to a Disability
- April 16, 2015: Closing date for Advance Registration
- May 26, 2015: Closing date to submit either electronic or written comments to http://www.regulations.gov or FDA’s Division of Dockets Management, (HFA-305), Food and Drug Administration, 5360 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please include: Docket No. FDA-2015-N-0797.